ReviewRSC advances2018
The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer.
Jiayu Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it